NFKB1 and neoplasm: Notably, NF-κB functions as a central regulatory hub across these phases: while its activation during early immune responses promotes pro-inflammatory cytokine production and antitumor activity, persistent or dysregulated NF-κB signaling in chronic inflammation and within MDSCs contributes to immune suppression, checkpoint upregulation, and tumor immune escape [7].